Xtl Biopharmaceuticals (XTLB) Investment Gain (Loss) (2018 - 2024)
Xtl Biopharmaceuticals (XTLB) reported Investment Gain (Loss) of -$5,000 for the year ended Dec 31, 2025, compared with -$167,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Investment Gain (Loss) (2018 - 2024) Analysis & Trends
Dating back to the year ended Dec 31, 2018, Xtl Biopharmaceuticals' Investment Gain (Loss) record includes 8 years.
- Five-year annual Investment Gain (Loss) spans a low of -$747,000 in the year ended Dec 31, 2021 and a high of $1.53 million in the year ended Dec 31, 2022.
- According to Business Quant data, Investment Gain (Loss) came in at -$167,000 in the year ended Dec 31, 2024, $1.02 million in the year ended Dec 31, 2023 (-33.2%), $1.53 million in the year ended Dec 31, 2022 and -$747,000 in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investment Gain (Loss) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -279,000.00 |
| Mar 31, 2024 | 666,000.00 |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | -45,000.00 |
| Jun 30, 2023 | -178,000.00 |
| Mar 31, 2023 | -655,000.00 |
| Dec 31, 2022 | 2.53 Mn |
| Sep 30, 2022 | -649,000.00 |
| Jun 30, 2022 | -572,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Dec 31, 2021 | -1.59 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | -68,000.00 |
| Mar 31, 2021 | 1.04 Mn |
| Dec 31, 2020 | 174,000.00 |
| Sep 30, 2020 | -373,000.00 |
| Jun 30, 2020 | -216,000.00 |
| Mar 31, 2020 | 277,000.00 |
| Dec 31, 2019 | -877,000.00 |
| Sep 30, 2019 | -1.08 Mn |
API Access
Xtl Biopharmaceuticals Investment Gain (Loss) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=investment-gain-loss&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "investment-gain-loss", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=investment-gain-loss&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();